Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Vectorious; AstraZenca; Bayer AG; Boehringer Ingelheim; Brahms; Cardiac Dimensions; Cardior; CVRx; Edwards Lifesciences; Impluse Dynamics; Novartis; Occlutech; Respicardia; V-Wave; Novo Nordisk; Scirent
- Grant Support/Research Contract - Abbott Vascular; Vifor International
- Equity/Stock(s)/Options - Cordio